Skip to content

Clinical trials

Phase 2 Lung Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Country / region: Switzerland Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20052
20061
20103
20111
20121
20141
20161
20171
20181
20212
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting2
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Swiss Cancer Institute11
Boehringer Ingelheim1
ETOP IBCSG Partners Foundation1
European Organisation for Research and Treatment of Cancer - EORTC1
Incyte Corporation1
Iovance Biotherapeutics, Inc.1
Novartis Pharmaceuticals1
UNICANCER1
University Hospital, Basel, Switzerland1
University of Cologne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms21
Carcinoma, Non-Small-Cell Lung15
Adenocarcinoma of Lung6
Adenocarcinoma2
Adenocarcinoma, Bronchiolo-Alveolar2
Melanoma2
Pancreatic Neoplasms2
Biliary Tract Neoplasms1
Brain Neoplasms1
Bronchial Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.